Patents by Inventor Seyedhossein Aharinejad

Seyedhossein Aharinejad has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 9375460
    Abstract: The invention discloses the use of glutathione S-transferase Pb (GSTP1) for the prevention or treatment of cardiomyopathies or ischemic heart diseases and for the diagnosis thereof.
    Type: Grant
    Filed: May 13, 2014
    Date of Patent: June 28, 2016
    Assignee: Medizinische Universitaet Wien
    Inventor: Seyedhossein Aharinejad
  • Publication number: 20140302002
    Abstract: The invention discloses the use of glutathione S-transferase Pb (GSTP1) for the prevention or treatment of cardiomyopathies or ischemic heart diseases and for the diagnosis thereof.
    Type: Application
    Filed: May 13, 2014
    Publication date: October 9, 2014
    Inventor: Seyedhossein AHARINEJAD
  • Patent number: 8758745
    Abstract: The invention discloses the use of glutathione S-transferase P1 (GSTP1) for the prevention or treatment of cardiomyopathies or ischemic heart diseases and for the diagnosis thereof.
    Type: Grant
    Filed: October 28, 2010
    Date of Patent: June 24, 2014
    Assignee: Medizinische Universitaet Wien
    Inventor: Seyedhossein Aharinejad
  • Publication number: 20120213761
    Abstract: The invention discloses the use of glutathione S-transferase P1 (GSTP1) for the prevention or treatment of cardiomyopathies or ischemic heart diseases and for the diagnosis thereof.
    Type: Application
    Filed: October 28, 2010
    Publication date: August 23, 2012
    Applicant: MEDIZINISCHE UNIVERSITAET WIEN
    Inventor: Seyedhossein Aharinejad
  • Publication number: 20090317403
    Abstract: Disclosed is the use of inhibitors of CSF-1 activity for preparing a medicament for the treatment of tumor diseases.
    Type: Application
    Filed: May 13, 2009
    Publication date: December 24, 2009
    Inventors: Seyedhossein Aharinejad, Reinhold Hofbauer
  • Publication number: 20060105345
    Abstract: The invention relates to a method for diagnosing lung transplantation rejection comprising determining the amount of Hepatocyte Growth Factor (HGF) in a body fluid or tissue sample of a patient who has undergone lung transplantation.
    Type: Application
    Filed: March 4, 2004
    Publication date: May 18, 2006
    Inventor: Seyedhossein Aharinejad